6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)
| 中文名称 | 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%) |
|---|---|
| 中文同义词 | 化合物 T13075L;化合物 T-705RTP sodium;T-705RTP 纳盐 (>75%) |
| 英文名称 | 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%) |
| 英文同义词 | 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%);6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>T-705RTP sodium;T-705RTP Sodium Salt (>75%);T 705RTP sodium,T705RTP sodium;T-705RTP Sodium Salt |
| CAS号 | 356783-10-3 |
| 分子式 | C10H16FN3NaO15P3 |
| 分子量 | 553.15 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 356783-10-3.mol |
| 结构式 | ![6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%) 结构式](CAS/20211123/GIF/356783-10-3.gif) |
6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%) 性质
| 熔点 | >123°C (dec.) |
|---|---|
| 储存条件 | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| 溶解度 | 可微溶于水 |
| 形态 | 固体 |
| 颜色 | 淡黄色至淡米色 |
6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%) 用途与合成方法
T-705RTP sodium 是一种具有具有选择性和 GTP 竞争性的流感病毒 RNA 聚合酶 (RNA polymerase) 抑制剂，IC50 为 0.14 μM，Ki 为 1.52 μM。T-705RTP sodium 是 T-705 的活性三磷酸盐代谢产物，具有有效的抗流感病毒活性。
T-705RTP sodium and T-705RMP are detected in MDCK cells treated with T-705. T-705RTP sodium inhibits influenza virus RNA polymerase activity in a dose-dependent and a GTP-competitive manner.
T-705RTP sodium inhibits the incorporation of ATP and GTP in a competitive manner with K
i
values of 7.72 and 1.56 μM, respectively. T-705RTP sodium inhibits the incorporation of CTP in a mixed-type manner with a K
i
value of 11.3 μM, and also inhibits the incorporation of UTP in a noncompetitive manner.
The incorporation of a single molecule of T-705RTP sodium (10-1000 μM) inhibits influenza virus RNA strand extension.